about
An Overview of Current Regulatory Requirements for Approval of Biosimilar InsulinsBiosimilar Insulins: Basic ConsiderationsAccuracy in blood glucose measurement: what will a tightening of requirements yield?Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial)Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetesResidual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the Randomized DIATOR TrialOutcome Measures for Artificial Pancreas Clinical Trials: A Consensus ReportAP@home: The Artificial Pancreas Is Now at HomeComparison of the numerical and clinical accuracy of four continuous glucose monitorsDay and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-managementAP@home: a novel European approach to bring the artificial pancreas home.Nonlinear metabolic effect of insulin across the blood glucose range in patients with type 1 diabetes mellitusThe systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial).Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol.Prediction of the risk to develop diabetes-related late complications by means of the glucose pentagon model: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring study.Enhancement of blood glucose lowering effect of a sulfonylurea when coadministered with an ACE inhibitor: results of a glucose-clamp study.Continuous glucose monitoring: an overview of today's technologies and their clinical applications.Variability of insulin absorption and insulin action.Reduction of postprandial glycemic excursions in patients with type 1 diabetes: a novel human insulin formulation versus a rapid-acting insulin analog and regular human insulin.Biosimilar insulins: how similar is similar?Continuous glucose monitoring by means of the microdialysis technique: underlying fundamental aspects.Hypoglycemia warning signal and glucose sensors: requirements and concepts.Continuous glucose monitoring with glucose sensors: calibration and assessment criteria.Glucose sensors and the alternate site testing-like phenomenon: relationship between rapid blood glucose changes and glucose sensor signals.Impact of Biosimilar Insulins on Clinical Practice: Meeting ReportOral insulin reloaded: a structured approachHow to Assess the Quality of Glucose Clamps? Evaluation of Clamps Performed With ClampArt, a Novel Automated Clamp Device.Measurement of insulin absorption and insulin action.Quality of HbA1c Measurement in the Practice: The German PerspectiveDevice connectivity: the next big wave in diabetes.HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple DaTime Delay of CGM Sensors: Relevance, Causes, and Countermeasures.Insulin Pump and CGM Usage in the United States and Germany: Results of a Real-World Survey With 985 SubjectsIQWiG Reanalyzes and Raises Questions About an Article by Ly et al Which Concluded Low Glucose Suspend Is Very Beneficial.Continuous glucose monitoring accuracy results vary between assessment at home and assessment at the clinical research centerEASD diabetes technology meeting: medical associations are on track.Biosimilar Insulin and Costs: What Can We Expect?Real-time improvement of continuous glucose monitoring accuracy: the smart sensor conceptConsiderations for an institution for evaluation of diabetes technology devices to improve their quality in the European Union.Future directions for insulin therapy and diabetes treatment.
P50
Q26823562-7AC5F65E-DBC6-4A35-94D9-2DF2923177A4Q28646059-8749B7E7-25E4-425F-85AD-19EABD9D3940Q28728177-DB238B21-A376-4A33-A809-11F76A6307CEQ28731029-DBBDAF43-D458-46FF-A593-C29D5666FCBDQ28732681-60EDB88A-973B-4EAC-935D-11154AE6736CQ28742007-77A7DF9E-A7E2-49D9-B6A5-15610F5E7C31Q30276532-E10644C0-EBCA-4DA4-A21C-5B84E6CA6416Q30354088-2412752B-3365-47B0-A4FF-FF46039B1E67Q30370423-4AC24AD7-3DBA-4BE9-91CF-8294FAE50166Q30409243-0F008965-1D0B-4CE7-823D-A0D4CAEDA917Q30424293-4BC64706-D56F-4ECA-8470-13E96E4A2BE3Q30431612-176B0EA7-3674-4054-A854-4E3E4F38D001Q31132948-1D251A0E-EFA6-4E94-8B0D-858E17B1E352Q34151693-858D9F52-B32E-4AB6-B73B-C14B5AB284B0Q34329297-2291E6BE-75A0-4787-B4E1-9FE49CB5D0FCQ34557929-310521E8-32F5-409F-AD46-5B5A65BA4D24Q34776264-54B954F2-E81D-48B1-90BE-857C0E41EFFEQ35008637-E7E9DD16-A034-4E64-A5E4-A43EF819357AQ35337607-60D85133-DB29-4FEC-9E83-0CBD9EBEEB1EQ35337749-804D0823-624A-4962-85F0-7250B15AAFF4Q35544387-D924D606-CDDF-409B-A0FE-C54E6594C34FQ35544390-A4E444B1-69D5-4A79-8FEA-C74D7A7C94C1Q35544394-0EE0FB17-C35F-4B88-96D3-3C93CFB21EB1Q35591344-EF1451C1-FFF3-4D20-8747-30D743551082Q35679047-F8824441-9157-4AEB-93E5-BC03790812B0Q35682832-C99C3051-1BF5-4B3B-92D8-8E0E06A0D00DQ35918397-759F7EAA-E3EE-4AF8-AE72-BAD1A6283203Q35997985-199353A1-F84B-457C-BD92-C9562054BCE2Q36158933-5A486D51-4D9E-4019-9E6D-DF82961F8E52Q36158969-F232CE10-734F-4206-A8EF-C4BB8C0B419FQ36159014-979AAE80-45D0-4520-A6DE-97FFC2C5F508Q36340516-5A1874DA-6F77-4519-A15C-7ACB49C3D8D7Q36340536-7E19C165-E13D-4292-93CD-D3A5D835BF6AQ36535939-61358A0C-001F-4581-A42B-B0E28E8842D4Q36605708-ADA30A4B-7D41-4D5F-9F75-68828C5171F6Q36608985-A564D907-7F45-4C06-950A-E93D3A1DB84CQ36638889-F82C8EB3-836E-4981-8756-12FBE135436CQ36720416-7F410876-A7F6-4707-81D6-D44B23545F47Q37080674-3F10322E-7DB3-4E0F-B498-D070F4ADBC23Q37136651-A7A068F3-B64C-4942-A457-2FCBFFB9E451
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Lutz Heinemann
@ast
Lutz Heinemann
@en
Lutz Heinemann
@es
Lutz Heinemann
@nl
type
label
Lutz Heinemann
@ast
Lutz Heinemann
@en
Lutz Heinemann
@es
Lutz Heinemann
@nl
prefLabel
Lutz Heinemann
@ast
Lutz Heinemann
@en
Lutz Heinemann
@es
Lutz Heinemann
@nl
P214
P214
P31
P496
0000-0003-2493-1304
P7859
lccn-nb2015002938